Related references
Note: Only part of the references are listed.Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 (vol 176, pg 610, 2019)
Olga L. Rojas et al.
CELL (2019)
Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients
Jan W. Traub et al.
JOURNAL OF NEUROINFLAMMATION (2019)
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+T lymphocytes and B cells
Joana Machado-Santos et al.
BRAIN (2018)
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
Hanane Touil et al.
JOURNAL OF NEUROINFLAMMATION (2018)
An updated histological classification system for multiple sclerosis lesions
Tanja Kuhlmann et al.
ACTA NEUROPATHOLOGICA (2017)
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
Robert C. Sergott et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model
D. Haeusler et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells
Tilman Schneider-Hohendorf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
Luisa M. Villar et al.
ARCHIVES OF NEUROLOGY (2012)
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system
Catherine Larochelle et al.
BRAIN (2012)
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
Marie T. Fischer et al.
BRAIN (2012)
Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
Raquel Planas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS
Ken Flanagan et al.
PLOS ONE (2012)
Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
Veit Rothhammer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
Norman Putzki et al.
EUROPEAN NEUROLOGY (2010)
Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells
Anouk Caraux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment
P Wipfler et al.
Multiple Sclerosis Journal (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Verena Brucklacher-Waldert et al.
BRAIN (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions
Ingo Bartholomaeus et al.
NATURE (2009)
Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
Werner Wenning et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Allergic and nonallergic delayed infusion reactions during natalizumab therapy
Kerstin Hellwig et al.
ARCHIVES OF NEUROLOGY (2008)
Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
Maria del Pilar Martin et al.
ARCHIVES OF NEUROLOGY (2008)
Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients
Raija L. P. Lindberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
M. Krumbholz et al.
NEUROLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies
Markus Krumbholz et al.
ARCHIVES OF NEUROLOGY (2007)
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
Olaf Stuve et al.
ARCHIVES OF NEUROLOGY (2006)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve et al.
ANNALS OF NEUROLOGY (2006)
Natalizumab effects on immune cell responses in multiple sclerosis
M Niino et al.
ANNALS OF NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
A Langer-Gould et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
MP Crawford et al.
BLOOD (2004)
Determinants of human B cell migration across brain endothelial cells
A Alter et al.
JOURNAL OF IMMUNOLOGY (2003)
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
T Kuhlmann et al.
BRAIN (2002)
Oligoclonal expansion of memory CD8(+) T cells in cerebrospinal fluid from multiple sclerosis patients
M Jacobsen et al.
BRAIN (2002)
Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis
BE Theien et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
